+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis



Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis



Journal of Primary Health Care 8(4): 325-334



INTRODUCTION Evidence for the effectiveness of drug treatment for depression in primary care settings remains limited, with little information on newer antidepressant classes. AIM To update an earlier Cochrane review on the effectiveness of antidepressants in primary care to include newer antidepressant classes, and to examine the efficacy of individual agents. METHODS Selection criteria included antidepressant studies with a randomly assigned placebo group where half or more subjects were recruited from primary care. The Cochrane Collaboration Depression, Anxiety and Neurosis (CCDAN) group searched multiple databases to identify eligible studies. Data extraction was performed independently by two reviewers. Data were analysed using Revman version 5.3.5. RESULTS In total, 17 papers and 22 comparisons were included for analysis. Significant benefits in terms of response were found for tricyclic antidepressants (TCA) with a relative risk (RR) = 1.23 (95% CI, 1.01-1.48), and serotonin selective reuptake inhibitors (SSRI) with a RR = 1.33 (95% CI, 1.20-1.48). Mianserin was effective for continuous outcomes. Numbers needed to treat (NNT) for TCA = 8.5; SSRI = 6.5; and venlafaxine = 6. Most studies were industry-funded and of a brief duration (≤ 8 weeks). There was evidence of publication bias. There were no studies comparing newer antidepressants against placebo. CONCLUSION Antidepressants such as TCA, SSRI, SNRI (serotonin-norepinephrine reuptake inhibitor) and NaSSA (noradrenergic and specific serotonergic antidepressant) classes appear to be effective in primary care when compared with placebo. However, in view of the potential for publication bias and that only four studies were not funded by industry, caution is needed when considering their use in primary care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048324628

Download citation: RISBibTeXText

PMID: 29530157

DOI: 10.1071/hc16008


Related references

Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliative Medicine 25(1): 36-51, 2011

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. Bmj 326(7397): 1014, 2003

Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. Journal of Clinical Psychiatry 72(2): 156-167, 2011

Antidepressants for the Acute Treatment of Bipolar Depression: A Systematic Review and Meta-Analysis. Yearbook of Psychiatry and Applied Mental Health 2012: 297-298, 2012

Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. Bmc Psychiatry 13: 140, 2013

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis. Cns Drugs 22(7): 587-602, 2008

Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. Journal of Neurology Neurosurgery and Psychiatry 82(8): 914-923, 2011

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. Journal of Clinical Psychiatry 69(9): 1404-1415, 2008

Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis. Addiction 110(1): 38-48, 2015

Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants. American Journal of Geriatric Psychiatry 19(3): 249-255, 2011

Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. JournalofAffectiveDisorders144(1-2):7, 2013

Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Annals of Family Medicine 3(5): 449-456, 2005

Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. Journal of Clinical Psychiatry 73(4): 486-496, 2012

Are Antipsychotics or Antidepressants Needed for Psychotic Depression? A Systematic Review and Meta-Analysis of Trials Comparing Antidepressant or Antipsychotic Monotherapy With Combination Treatment. Yearbook of Psychiatry and Applied Mental Health 2013: 312-314, 2013

Cognitive behaviour therapy for depression in primary care: systematic review and meta-analysis. Psychological Medicine 49(8): 1266-1274, 2019